Title : RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1.

Pub. Date : 2018 Feb 8

PMID : 29059158






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1. LY3009120 cyclin dependent kinase 4 Homo sapiens